Dr. Reddy’s Laboratories Ltd., India’s second-biggest drugmaker by revenue, said second-quarter group profit jumped 32 percent to 2.87 billion rupees ($64 million) on increased sales of generic drugs.
Sales increased to 18.9 billion rupees in the three months ended Sept. 30, from 18.5 billion rupees a year earlier, the company said in an e-mailed statement today.
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment